Last reviewed · How we verify
NCT05593341
Opioid Education in Total Knee Arthroplasty
NA trial testing Opioid education in person in Arthropathy of Knee in 42 participants. Completed in 11 September 2023.
11 September 2023
Quick facts
| Lead sponsor | Hospital for Special Surgery, New York |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 27 September 2022 |
| Primary completion | 11 September 2023 |
| Estimated completion | 11 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Opioid education in person
- Opioid education via video
Conditions studied
- Arthropathy of Knee — all drugs for Arthropathy of Knee →
- Post Operative Pain — all drugs for Post Operative Pain →
- Opioid Use — all drugs for Opioid Use →
- Opioid Abuse — all drugs for Opioid Abuse →
Sponsor
Hospital for Special Surgery, New York
Who can join
Adults 18 to 80, any sex, with Arthropathy of Knee or Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this experimental study is to compare different education intervention on opioid education for patients undergoing total knee arthroplasty. The specific research questions to address are: 1. Does perioperative education pathway reduce opioid refill requests? 2. Is education pathway that focuses on pain management provided in-person and via video in repeated sessions more effective than current standard of care education consisting of a single exposure given as part of a broader preoperative presentation covering multiple topics? 3. Is there a difference between education provided in-person vs video? 4. Does perioperative education improve compliance with multimodal analgesia? 5. Does perioperative education improve appropriate opioid storage? 6. Does perioperative education improve appropriate opioid disposal? Enrolled patients will be assigned at random to one of 3 study groups. Group 1 (control): Patients are referred to the hospital's standard 1-hour virtual patient education webinar prior to surgery. Group 2 (in-person): Patients will receive two in-person education sessions (1st session before surgery and 2nd session after surgery). Patients will also receive portable document format (pdf) handouts about opioid and pain management. Group 3 (video): Patients will receive two video education sessions (1st session before surgery and 2nd session after surgery). Patients will also receive pdf handouts about opioid and pain management.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparing modalities of opioid education in patients undergoing total knee arthroplasty: a randomized pilot trial.
Sheetz M, Puglisi A, Trentalange M, Reichel J, et al · · 2026 · PMID 39327049 · DOI 10.1136/rapm-2024-105701
Verify or expand the search:
- PubMed search for NCT05593341
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthropathy of Knee
Currently open trials in the same condition.
- NCT07180953 — Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty · Phase 4 · recruiting
- NCT05290818 — Total Versus Robotic Assisted Unicompartmental Knee Replacement · NA · recruiting
- NCT06832995 — Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties · active not recruiting
- NCT03869996 — Total Knee Arthroplasty: Fast Track Protocol is the Future? · NA · recruiting
- NCT03674697 — The Effect of Light Therapy on Post-Surgical Pain · NA · active not recruiting
Other Hospital for Special Surgery, New York trials
Trials by the same sponsor.
- NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
- NCT06567873 — Gastric Ultrasound Assessment for Patients Taking Cannabis · completed
- NCT07217964 — Natural Matrix Protein · enrolling by invitation
- NCT06798493 — CSS-SR Validation Study · enrolling by invitation
- NCT06180486 — Mindfulness Meditation Intervention Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05593341 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital for Special Surgery, New York
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05593341.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing